Selection of high-producing CHO cells using NPT selection marker with reduced enzyme activity
Abstract
We developed an expression system that aimed to increase the proportion of high producers in a transfected cell population in order to reduce the effort in clone screening. The principle is based on the impairment of the selection marker. Twelve single‐point mutations in more or less conserved domains of the resistance marker gene neomycin‐phosphotransferase (NPT) resulted in different degrees of reduced enzyme activity, depending on the amino acid conservation and the kind of amino acid exchange. In all transfected, mutant‐NPT bearing CHO‐DG44 cell pools surviving the selection with G418, the ratio of high‐producing cells to total cell number was higher than in pools selected with wildtype‐NPT. Furthermore, these pools showed, in comparison to wildtype‐NPT selected pools, not only higher NPT‐RNA levels but also increased specific productivities and higher titers of a coexpressed biopharmaceutically relevant product. Elevated productivity could be ascribed to higher gene copy numbers, integration into chromatin regions with higher transcriptional activity, or a combination of both effects. Thus, the use of NPT‐mutants as selection markers is suitable for the enrichment of high producers in a transfected CHO‐DG44 cell population, since cell survival is achieved only if the enzymatic impairment of the cointegrated resistance marker is compensated by a higher expression level. © 2005 Wiley Periodicals, Inc.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
STAR elements were discovered by a genomic screen of elements that would increase transgene expression.
“They were discovered by a genomic screen of elements that would increase transgene expression.(Kwaks et al., 2003;Sautter and Enenkel, 2005;Hoeksema et al., 2011;Van Blokland et al., 2011;Harraghy et al., 2015).”
From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Sautter and Enenkel, 2005
Cites
Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mr.57.1.138-163.1993 · Cited by 1,195 · see citing works
Aminoglycosides: Activity and Resistance
Mingeot‐Leclercq, M., Glupczynski, Y., & Tulkens, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.727 · Cited by 1,105 · see citing works
Yoshimura, T., Yuhki, N., Moore, S. K., Appella, E., Lerman, M. I., & Leonard, E. J. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)80590-3 · Cited by 589 · see citing works
Effect of gamma rays at the dihydrofolate reductase locus: Deletions and inversions
Urlaub, G., Mitchell, P. J., Käs, E., Chasin, L. A., Funanage, V. L., Myoda, T. T., & Hamlin, J. L. (1986) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01671941 · Cited by 222 · see citing works
Yenofsky, R. L., Fine, M., & Pellow, J. W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.9.3435 · Cited by 171 · see citing works
Analysis of Biological Selections for High-Efficiency Gene Targeting
Hanson, K. D., & Sedivy, J. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.45 · Cited by 83 · see citing works
RAMPAGE: Promoter Activity Profiling by Paired-End Sequencing of 5′-Complete cDNAs
Batut, P. J., & Gingeras, T. (2013) · Current Protocols in Molecular Biology · doi:10.1002/0471142727.mb25b11s104 · Cited by 79 · see citing works
Martin, P., Jullien, E., & Courvalin, P. M. (1988) · Molecular Microbiology · doi:10.1111/j.1365-2958.1988.tb00070.x · Cited by 78 · see citing works
Dot assay for neomycin phosphotransferase activity in crude cell extracts
Platt, S. G., & Yang, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90429-5 · Cited by 67 · see citing works
Blázquez, J., DAVIES, J. E., & Moreno, F. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb00798.x · Cited by 23 · see citing works
A sensitive and simple assay for neomycin phosphotransferase II activity in transgenic tissue
Cabanes-Bastos, E., Day, A. G., & Lichtenstein, C. P. (1989) · Gene · doi:10.1016/0378-1119(89)90371-5 · Cited by 23 · see citing works
Kocabıyık, S., & Perlin, M. H. (1992) · FEMS Microbiology Letters · doi:10.1016/0378-1097(92)90529-w · Cited by 18 · see citing works
Kocabıyık, S., & Perlin, M. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91715-3 · Cited by 16 · see citing works
Determination of transient or stable neo expression levels in mammalian cells
Duch, M., Paludan, K., Pedersen, L., Jørgensen, P., Kjeldgaard, N. O., & Pedersen, F. S. (1990) · Gene · doi:10.1016/0378-1119(90)90373-y · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Advances in Mammalian cell line development technologies for recombinant protein production
Lai, T., Yang, Y., & Ng, S. (2013) · Pharmaceuticals · doi:10.3390/ph6050579 · Cited by 322 · see citing works
Therapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296 · see citing works
Recent advances in mammalian protein production
Bandaranayake, A. D., & Almo, S. C. (2014) · FEBS Letters · doi:10.1016/j.febslet.2013.11.035 · Cited by 222 · see citing works
Ho, S. C. L., Bardor, M., Feng, H., Mariati, Tong, Y. W., Song, Z., Yap, M. G. S., & Yang, Y. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.09.023 · Cited by 148 · see citing works
Transcriptome and Proteome Profiling to Understanding the Biology of High Productivity CHO Cells
Nissom, P. M., Sanny, A., Kok, Y. J., Hiang, Y. T., Chuah, S. H., Tan, K. S., Lee, Y. Y., Wong, K. T. K., Hu, W., Sim, M. Y. G., et al. (2006) · Molecular Biotechnology · doi:10.1385/mb:34:2:125 · Cited by 120 · see citing works
Accelerated Clone Selection for Recombinant CHO Cells Using a FACS‐Based High‐Throughput Screen
DeMaria, C. T., Cairns, V. R., Schwarz, C., Zhang, J., Guerin, M., Zuena, E., Estes, S. D., & Karey, K. P. (2007) · Biotechnology Progress · doi:10.1021/bp060298i · Cited by 86 · see citing works
Chartrain, M. M., & Chu, L. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108786786367 · Cited by 83 · see citing works
Zhou, H., Liu, Z., Sun, Z., Huang, Y., & Yu, W. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.03.020 · Cited by 65 · see citing works
Ho, S. C. L., Mariati, Yeo, J. H. M., Fang, S. G., & Yang, Y. (2014) · Molecular Biotechnology · doi:10.1007/s12033-014-9809-2 · Cited by 62 · see citing works
Florin, L., Pegel, A., Becker, E., Hausser, A., Olayioye, M. A., & Kaufmann, H. (2009) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2009.02.014 · Cited by 59 · see citing works
High‐throughput screening and selection of mammalian cells for enhanced protein production
Priola, J. J., Calzadilla, N., Baumann, M., Borth, N., Tate, C. G., & Betenbaugh, M. J. (2016) · Biotechnology Journal · doi:10.1002/biot.201500579 · Cited by 53 · see citing works
NG, S., Wang, D. I. C., & YAP, M. (2007) · Metabolic Engineering · doi:10.1016/j.ymben.2007.01.001 · Cited by 51 · see citing works
Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones
Yang, W., Zhang, J., Xiao, Y., Li, W., & Wang, T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.858478 · Cited by 43 · see citing works
Generation of monoclonal antibody-producing mammalian cell lines
Ho, S. C., Tong, Y. W., & Yang, Y. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.8 · Cited by 42 · see citing works
Attallah, C. V., Etcheverrigaray, M., Kratje, R. B., & Oggero, M. (2017) · Protein Expression and Purification · doi:10.1016/j.pep.2017.01.003 · Cited by 40 · see citing works
Chin, C. L., Chin, H. K., Chin, C. S. H., Lai, E. T., & Ng, S. K. (2015) · BMC Biotechnology · doi:10.1186/s12896-015-0145-9 · Cited by 37 · see citing works
Fan, L., Frye, C. C., & Racher, A. J. (2013) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.13.56 · Cited by 35 · see citing works
Yeo, J. H. M., Ho, S. C. L., Mariati, M., Koh, E. Y. C., Tay, S. J., Woen, S., Zhang, P., & Yang, Y. (2017) · Biotechnology Journal · doi:10.1002/biot.201700175 · Cited by 34 · see citing works
Harraghy, N., Calabrese, D., Fisch, I., Girod, P., LeFourn, V., Regamey, A., & Mermod, N. (2015) · Biotechnology Journal · doi:10.1002/biot.201400649 · Cited by 32 · see citing works
A novel, high stringency selection system allows screening of few clones for high protein expression
VANBLOKLAND, H., Kwaks, T., Sewalt, R. G. A. B., Verhees, J., Klaren, V. N. A., Siersma, T. K., Korse, J. W. M., Teunissen, N. C., Botschuijver, S., & VANMER, C. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2006.09.023 · Cited by 25 · see citing works
Ho, S. C. L., Koh, E. Y. C., Soo, B. P. C., Mariati, Chao, S., & Yang, Y. (2016) · BMC Biotechnology · doi:10.1186/s12896-016-0300-y · Cited by 22 · see citing works
Cairns, V. R., DeMaria, C. T., Poulin, F., Sancho, J., Liu, P., Zhang, J., Campos‐Rivera, J., Karey, K. P., & Estes, S. D. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23219 · Cited by 18 · see citing works
Methods to create a stringent selection system for mammalian cell lines
Blokland, H. J. M. V., Hoeksema, F., Siep, M., Otte, A. P., & Verhees, J. (2011) · Cytotechnology · doi:10.1007/s10616-011-9354-9 · Cited by 16 · see citing works
Ng, S. K. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-352-3_11 · Cited by 15 · see citing works
Grindes, L., Florimond, C., Ribault, S., Raymond, C., Dieryck, W., Joucla, G., & Corbin, C. (2023) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2023.05.001 · Cited by 14 · see citing works
Kotsopoulou, E., Bosteels, H., Chim, Y.-T., Pegman, P. M., Stephen, G. G., Thornhill, S. I., Faulkner, J. D., & Uden, M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.02.004 · Cited by 12 · see citing works
Large Scale Suspension Culture of Mammalian Cells
Alldread, R. M., Birch, J. R., Metcalfe, H. K., Farid, S. S., Racher, A. J., Young, R. J., & Khan, M. (2014) · Wiley eBooks · doi:10.1002/9783527683321.ch12 · Cited by 9 · see citing works
Li, Q., Yan, R., Yang, Y. X., Mi, C., Jia, Y., & Wang, T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.840600 · Cited by 6 · see citing works
Development and qualification of a high-yield recombinant human Erythropoietin biosimilarPreprint
Nag, K., Islam, M. J., Khan, M. M. R., Chowdhury, M. M. R., Sarker, M. E. H., Kumar, S., Khan, H., Chakraborty, S., Roy, R., Roy, R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.22.525046 · Cited by 6 · see citing works
Development of Magoh protein‐overexpressing HEK cells for optimized therapeutic protein production
Mufarrege, E. F., Benizio, E., Prieto, C. C., Chiappini, F. A., Rodríguez, M. C., Etcheverrigaray, M., & Kratje, R. B. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1915 · Cited by 3 · see citing works
Raigani, M., Namdar, P., Barkhordari, F., Seyedjavadi, S. S., Rahimpour, A., & Adeli, A. (2025) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2025.2454335 · Cited by 1 · see citing works
Antibody Expression from Bacteria to Transgenic Animals
Stephens, P. E., & Sweeney, B. (2011) · Modecular medicine and medicinal · doi:10.1142/9781848166295_0006 · Cited by 1 · see citing works
Recombinant protein expression in mammalian cells
Joshi, M., Verma, P., Mago, P., Agrawal, Y., Gunwal, I., Khurana, S., Tanwar, J., Yadav, U., & Yadav, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-98388-4.00008-3 · Cited by 1 · see citing works
Chin, C. L., Chin, H. K., Chin, C. S. H., Lai, E. T., & KongNg, S. (2015) · BMC Proceedings · doi:10.1186/1753-6561-9-s9-p10 · Cited by 1 · see citing works
Santoso, A., Wisnuwardhani, P. H., Kusumawati, A., Herawati, N., Rubiyana, Y., Septisetyani, E. P., & Nurainy, N. (2020) · IOP Conference Series Earth and Environmental Science · doi:10.1088/1755-1315/439/1/012006 · Cited by 1 · see citing works
Wang, W., Guo, X. H., Chen, S., Wang, T., Wang, F., Qin, L., & Wang, Y. (2020) · Process Biochemistry · doi:10.1016/j.procbio.2020.04.005 · Cited by 1 · see citing works
(2012) · Elsevier eBooks · doi:10.1533/9781908818096.421 · Cited by 1 · see citing works
Arbeitsgebiete der Bioverfahrenstechnik
(2013) · doi:10.1002/9783527673834.ch2 · Cited by 1 · see citing works
(2012) · Elsevier eBooks · doi:10.1016/b978-1-907568-37-4.50029-4 · Cited by 1 · see citing works
Becker, E. (2008) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-1784
Induzierbare Genexpression in humanen mesenchymalen Stammzellen
Drechsel, M. (2008) · doi:10.5282/edoc.8527
Schulz, T. W., Schlatter, S., Kaufmann, H., Enenkel, B., Hoffmann, H., & Grammatikos, S. (2010) · Springer eBooks · doi:10.1007/978-90-481-3419-9_62
Self-citationCell Line Development for Biomanufacturing Processes
Gadgil, M., & Hu, W. (2017) · doi:10.1002/9783527800599.ch12
Hu, J., Liu, M., Han, J., & Zeng, B. (2017) · International Conference on Biomedical and Biological Engineering (BBE) · doi:10.2991/bbe-17.2017.2
Advances in Production of Therapeutic Monoclonal Antibodies
Mahajan, R. V., Chand, S., Singh, M. P., Kestwal, A., & Singh, S. (2019) · Wiley eBooks · doi:10.1002/9781119460053.ch7
Recombinant expression systems
(2015) · CRC Press eBooks · doi:10.1201/b19077-7
Mirfeizollahi, A., & Kaghazian, H. (2025) · Journal of Cellular Biotechnology · doi:10.1177/23523689251359487
CHO endogenous weak promoters facilitating the development of high-yield cell lines
Tian, Y., Zhou, Y., Xiao, Z.-Y., Zhao, L., Ye, Q., & Tan, W.-S. (2026) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2026.05.005
Fieder, J., Schneider, S., & Fischer, S. (2026) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2026.2738418
- Authors
- Sautter, K., & Enenkel, B.
- Affiliations
- Boehringer Ingelheim (Germany) (DE)
- Corresponding author
- Enenkel, Barbara
- Venue
- Biotechnology and Bioengineering
- Publisher
- Wiley
- Published
- 2005-01-24
- Volume
- 89
- Issue
- 5
- Pages
- 530-538
- ISSN
- 0006-3592 (ISSN-L)
- 1097-0290
- OpenAlex
- W2029545026
- Cited by
- 51
- References
- 14
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2020: 4 · 2019: 1 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 2 · 2013: 5 · 2012: 2
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology and Bioengineering (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- neomycin phosphotransferase, reduced enzyme activity, G418 selection, CHO DG44 cells, clone screening, recombinant protein expression, gene copy number, transcriptional activity, point mutations, biopharmaceutical products
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Cell Survival, Clone Cells, Cricetulus, Genetic Markers, Gentamicins, Cricetinae, Molecular Sequence Data, Recombinant Proteins, Selection, Genetic, Transfection, Gene Expression, CHO Cells, Point Mutation, Protein Structure, Tertiary, Chemokine CCL2, Kanamycin Kinase, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review